Syndax(SNDX) - 2025 Q3 - Quarterly Report
Syndax(US:SNDX)2025-11-03 21:04UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 or Commission File Number: 001-37708 Syndax Pharmaceuticals, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 32-0162505 (State or Other Jurisdiction of Incorporation or Organization) 730 Third Avenue, 9th Floor New York, New York 10017 (Address of Principal ...